{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:58:48Z","timestamp":1781089128433,"version":"3.54.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:p>While the overall burden of leukemia has been studied, a comprehensive and up-to-date epidemiological analysis specifically focused on women of childbearing age (WCBA) using the latest global burden of disease 2021 data, particularly detailing the 4 major subtypes, is lacking. This knowledge gap limits the development of targeted healthcare policies for this unique demographic. This study aims to fill this gap by assessing the global, regional, and national burden of leukemia in WCBA from 1990 to 2021. We collected and analyzed data on acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia, and chronic myeloid leukemia (CML) in WCBA (aged 15\u201349) from the Global Burden of Disease Study 2021. We evaluated incidence, mortality, and disability-adjusted life years (DALYs), along with their age-standardized rates, categorized by age, region, country, and socio-demographic index. We also analyzed risk factors associated with leukemia-related DALYs and mortality. In 2021, an estimated 40,200 (95% UI 31.3, 45.1) new cases of leukemia among WCBA were reported globally. From 1990 to 2021, the age-standardized incidence rate declined by 22.4% (95% UI\u201331.2,\u201311.4), with larger reductions in age-standardized death rate (\u201334.2%; 95% UI\u201340.5,\u201325.7) and DALY rate (\u201343.1%; 95% UI\u201350.6,\u201330.6). The annual disease burden, in descending order, were AML, ALL, CLL, and CML. Epidemiological patterns showed significant regional differences, though CML declined across all regions. The burden of AML, CLL, and CML was positively correlated with age, while ALL peaked in the youngest (15\u201319) group. Risk factor analysis identified obesity (high-income, middle-aged) and occupational exposures (younger) as significant contributors. While the overall leukemia burden in WCBA has decreased globally, significant disparities persist by subtype, age, and region, with AML remaining the dominant burden. These findings underscore the need for tailored public health strategies and resource allocation to address high-risk populations and specific leukemia subtypes.<\/jats:p>","DOI":"10.1097\/md.0000000000047217","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:24Z","timestamp":1769191344000},"page":"e47217","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Global burden of leukemia in women of child-bearing age, 1990 to 2021: An update from the Global Burden of Disease Study 2021"],"prefix":"10.1097","volume":"105","author":[{"given":"Xing-Biao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"},{"name":"Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou, China"},{"name":"Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangzhou, China"},{"name":"Department of Clinical Medicine, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Han","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"},{"name":"Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou, China"},{"name":"Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangzhou, China"},{"name":"Department of Clinical Medicine, Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Ling","sequence":"additional","affiliation":[{"name":"Dongguan University of Technology-Conservatoire National des Arts er Metrers (DGUT-CNAM) Institute, Dongguan University of Technology, Dongguan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Jian","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8508-5450","authenticated-orcid":false,"given":"Zi-Yuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China"},{"name":"Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou, China"},{"name":"Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1002\/cncr.31669","article-title":"Toward the potential cure of leukemias in the next decade.","volume":"124","author":"Kantarjian","year":"2018","journal-title":"Cancer"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions.","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia.","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41408-022-00756-9","article-title":"Chronic lymphocytic leukemia treatment algorithm 2022.","volume":"12","author":"Hampel","year":"2022","journal-title":"Blood Cancer J"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0140-6736(21)01204-6","article-title":"Chronic myeloid leukaemia.","volume":"398","author":"Cortes","year":"2021","journal-title":"Lancet"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40364-024-00649-y","article-title":"Global, regional, and national burden of acute myeloid leukemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.","volume":"12","author":"Zhou","year":"2024","journal-title":"Biomarker Res"},{"key":"R7-20260610","first-page":"839","article-title":"The burden of acute lymphoid leukemia among adolescents and young adults in the Western Pacific Region: evidence from Global Burden Disease 2019.","volume":"35","author":"Yang","year":"2024","journal-title":"Cancer Causes Control"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"580759","DOI":"10.3389\/fonc.2020.580759","article-title":"Global, regional, and national burden of chronic myeloid leukemia, 1990-2017: a systematic analysis for the global burden of disease study 2017.","volume":"10","author":"Lin","year":"2020","journal-title":"Front Oncol"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12938-021-00973-6","article-title":"The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019.","volume":"21","author":"Yao","year":"2022","journal-title":"Biomed Eng Online"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability(YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The world health organization (WHO) classification of the myeloid neoplasms.","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.eclinm.2024.102713","article-title":"Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021.","volume":"74","author":"Sun","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","article-title":"Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the global burden of disease study 2021.","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","article-title":"Confidence intervals for directly standardized rates: a method based on the gamma distribution.","volume":"16","author":"Fay","year":"1997","journal-title":"Stat Med"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2012-02-387092","article-title":"Meeting the challenge of hematologic malignancies in sub-Saharan Africa.","volume":"119","author":"Gopal","year":"2012","journal-title":"Blood"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ijc.23176","article-title":"Overweight and obesity and incidence of leukemia: a .meta-analysis of cohort studies.","volume":"122","author":"Larsson","year":"2008","journal-title":"Int J Cancer"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bph.16162","article-title":"Understanding the interaction between leukaemia stem cells and their microenvironment to improve therapeutic approaches.","volume":"181","author":"Martinez","year":"2024","journal-title":"Br J Pharmacol"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3109\/10408444.2013.818618","article-title":"Formaldehyde exposure and leukemia: critical review and reevaluation of the results from a study that is the focus for evidence of biological plausibility.","volume":"43","author":"Gentry","year":"2013","journal-title":"Crit Rev Toxicol"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia.","volume":"16","author":"Bhansali","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R21-20260610","first-page":"239","article-title":"Acute leukemia in women.","volume":"6","author":"Lo-Coco","year":"2010","journal-title":"Women\u2019s Health"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaclp.2022.12.006","article-title":"Association between depression before hematopoietic stem cell transplantation and posttransplant survival: a systematic review and meta-analysis.","volume":"64","author":"Guillaume","year":"2023","journal-title":"J Acad Consul Liaison Psychiatry"},{"key":"R23-20260610","first-page":"174","article-title":"Maternal and perinatal outcomes in pregnant women with leukemia.","volume":"33","author":"Nomura","year":"2011","journal-title":"Revi Bras Ginecol Obstet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:02:17Z","timestamp":1781085737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047217","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}